CRO SERVICES
Therapeutic Areas
Bringing new compounds to market can be complex and costly. SRA Global Clinical Development professionals have specialized therapeutic expertise that can cost-effectively help shorten your time to market. We apply our knowledge across the spectrum of Phase I-IV studies in the following indications:
- Analgesia and Pain Management – Our work with investigational drugs and marketed compounds for chronic and acute pain indications includes clinical study design, scientific and regulatory issues, clinical trial conduct, pain assessment methodologies, and clinical and commercial factors.
- Diabetes – We have provided clinical support for more than 40 related endocrinology clinical trials, from early-stage advice to product approval.
- Infectious Diseases – Our experience covers every aspect of anti-infective product development – from early-stage strategic advice to product approval.
- Neurology – We have worked on investigational and/or marketed drugs to treat a wide range of adult and pediatric disorders, including Alzheimer’s disease, epilepsy, migraine, multiple sclerosis, neuropathic pain, Parkinson’s disease and stroke.
- Oncology – Our work spans adult and pediatric oncology with specialized expertise in investigational and/or marketed drugs for oncology and related projects, cytotoxins, biologics and agents.
- Psychiatry – We have broad experience developing compounds for psychiatric indications, including, ADHD, anxiety, alcohol dependence/drug abuse, depression and bipolar depression, mania, schizophrenia and smoking cessation.